バイオフィルム治療市場- 世界の産業規模、シェア、動向、機会、予測、製品タイプ別、エンドユーザー別、地域別、競合市場別、2020-2030F

バイオフィルム治療の世界市場規模は2024年に17億5,000万米ドルとなり、予測期間では2030年までCAGR 5.47%で大きな成長が予測されています。

世界のバイオフィルム治療市場は、近年著しい成長とイノベーションを目の当たりにしており、ヘルスケアにおける有望なフロンティアを提供しています。バイオフィルムは、細菌、真菌、その他の微生物を含む微生物の複雑な共同体であり、表面に付着して保護マトリックスを形成します。このようなバイオフィルムは様々な産業や医療現場で見られ、ヘルスケア、環境管理、工業プロセスにおいて重要な課題を引き起こしています。バイオフィルムに対する理解が進むにつれて、それに対抗する効果的な治療法を開発する能力も向上しています。WHO（2023年）によると、抗菌薬耐性（AMR）は世界の公衆衛生と開発の大きな脅威です。2019年、細菌性AMRは127万人の死亡を引き起こし、495万人に寄与しました。ヒト、動物、植物における抗菌薬の誤用と過剰使用は、耐性を促進します。AMRは低・中所得国に不釣り合いに影響を及ぼし、世界の貧困と不平等を悪化させています。

バイオフィルムは、配水システム、工業用パイプライン、医療機器など多様な環境に存在するユビキタスなものです。ヘルスケアでは、バイオフィルムに関連した感染症は、従来の抗生物質や免疫系の反応に耐性を持つため、深刻な脅威となっています。このような感染症は、慢性疾患や医療費の増加、さらには死亡につながる可能性があります。そのため、効果的なバイオフィルム治療戦略の開発は、医療・製薬業界における最重要課題となっています。

バイオフィルムがもたらす課題に対する意識の高まりが、効果的な治療オプションに対する需要を後押ししています。ヘルスケア専門家も患者も同様に、特殊なバイオフィルム治療の必要性を認識しています。バイオテクノロジー、ナノテクノロジー、微生物学の融合は、革新的な治療ソリューションの開発を促進しています。これらの進歩は、バイオフィルム形成を破壊し、治療効果を高めるための標的アプローチを可能にしています。世界のヘルスケア支出が増加し続ける中、先進的なバイオフィルム治療ソリューションへの投資意欲が高まっています。政府や民間企業は、この分野の研究開発支援にリソースを割いています。抗菌薬耐性の憂慮すべき増加は、代替治療戦略の必要性を際立たせています。バイオフィルムに関連した感染症は抗生物質に対して耐性であることが知られており、バイオフィルムに特異的な治療法の開発は極めて重要です。バイオフィルム治療はヘルスケアに限定されるものではないです。食品加工、水管理、石油・ガスなどの産業においても重要です。バイオフィルム治療の多用途性は、市場の可能性を広げています。

主な市場促進要因

ヘルスケア関連感染（HAI）の増加が世界のバイオフィルム治療市場を牽引

主な市場課題

バイオフィルム生物学に対する理解の浅さ

主要市場動向

技術の進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のバイオフィルム治療市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（デブリードマン機器、ガーゼとドレッシング、ジェル、軟膏とスプレー、移植片とマトリックス、ワイプ、パッドと洗浄液）
  • 創傷の種類別（火傷および開放創、糖尿病性足潰瘍、褥瘡、外傷および手術創、静脈性下肢潰瘍）
  • エンドユーザー別（在宅ケア施設、病院、ASC、創傷ケアセンター）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米のバイオフィルム治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のバイオフィルム治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域のバイオフィルム治療市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米のバイオフィルム治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのバイオフィルム治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収
• 製品の発売
• 最近の動向

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Smith+Nephew healthcare private Limited.
• ConvaTec Group plc
• Zimmer Biomet Holdings, Inc.
• Molnlycke Healthcare AB
• Organogenesis Inc.
• Integra LifeSciences Holdings Corp
• B. Braun Melsungen AG
• PAUL HARTMANN AG
• Medline Industries Inc.
• Welcare Industries S.p.A

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Biofilms Treatment Market was valued at USD 1.75 billion in 2024 and is anticipated to project significant growth in the forecast period with a CAGR of 5.47% through 2030. The global biofilms treatment market has witnessed significant growth and innovation in recent years, offering a promising frontier in healthcare. Biofilms are complex communities of microorganisms, including bacteria, fungi, and other microorganisms, that adhere to surfaces and form protective matrices. These biofilms are found in various industries and medical settings, causing significant challenges in healthcare, environmental management, and industrial processes. As our understanding of biofilms has advanced, so too has our ability to develop effective treatments to combat them. According to WHO (2023), antimicrobial resistance (AMR) is a major global public health and development threat. In 2019, bacterial AMR caused 1.27 million deaths and contributed to 4.95 million. Misuse and overuse of antimicrobials in humans, animals, and plants drive resistance. AMR disproportionately affects low- and middle-income countries, worsening poverty and inequality worldwide.

Biofilms are ubiquitous, existing in diverse environments such as water distribution systems, industrial pipelines, and medical devices. In healthcare, biofilm-related infections pose a severe threat, as they are resistant to traditional antibiotics and immune system responses. These infections can lead to chronic illnesses, increased healthcare costs, and even mortality. Therefore, the development of effective biofilm treatment strategies has become a top priority in the medical and pharmaceutical industries.

Increased awareness about the challenges posed by biofilms has driven demand for effective treatment options. Healthcare professionals and patients alike are recognizing the need for specialized biofilm treatments. The convergence of biotechnology, nanotechnology, and microbiology has facilitated the development of innovative treatment solutions. These advancements allow for targeted approaches to disrupt biofilm formation and enhance treatment efficacy. As global healthcare expenditure continues to rise, there is a growing willingness to invest in advanced biofilm treatment solutions. Governments and private sector players are allocating resources to support research and development efforts in this field. The alarming rise in antimicrobial resistance has accentuated the need for alternative treatment strategies. Biofilm-associated infections are notoriously resistant to antibiotics, making the development of biofilm-specific therapies crucial. Biofilm treatments are not limited to healthcare settings. They are also crucial in industries such as food processing, water management, and oil and gas. The versatility of biofilm treatments extends their market potential.

Key Market Drivers

Increasing Healthcare-Associated Infections (HAIs) is Driving the Global Biofilms Treatment Market

Healthcare-Associated Infections (HAIs) have been a persistent challenge in the medical field, causing significant morbidity and mortality worldwide. These infections are a consequence of bacteria forming biofilms on various medical devices, surfaces, and tissues, making them difficult to eradicate. As HAIs continue to rise, the demand for effective biofilm treatment solutions has fueled the growth of the Global Biofilms Treatment Market. Biofilms are complex, structured communities of microorganisms, primarily bacteria, that adhere to surfaces and produce a protective matrix of extracellular polymeric substances (EPS). These biofilms can be found in various healthcare settings, such as catheters, prosthetic devices, wound beds, and even on medical equipment. Biofilms play a critical role in HAIs as they enable bacteria to resist antibiotics, disinfectants, and host immune responses.

Key Market Challenges

Limited Understanding of Biofilm Biology

One of the primary challenges in biofilm treatment is the limited understanding of biofilm biology. Biofilms are highly heterogeneous and adaptive structures, making them difficult to study and target effectively. The complexity of biofilm formation, composition, and behavior varies greatly depending on the type of microorganisms involved, the host environment, and other factors. This variability makes it challenging to develop universal treatment approaches that can address all biofilm-related infections.

Key Market Trends

Technological Advancements

In recent years, the global biofilms treatment market has witnessed significant growth, thanks to the expanding technological advancements in the field. Biofilms, which are complex communities of microorganisms adhering to surfaces and encased in a protective matrix, have been a longstanding challenge in various industries, including healthcare, food processing, and water treatment. As our understanding of biofilms has deepened and innovative technologies have emerged, the global market for biofilms treatment has been on the rise.

Nanotechnology has played a pivotal role in biofilms treatment. Nanomaterials and nanoparticles have shown promising potential in disrupting biofilm formation and eradicating existing biofilms. These tiny structures can penetrate the protective matrix of biofilms, making them effective in various applications, including medical devices, wound care, and water treatment. Innovations in antimicrobial coatings have been instrumental in preventing biofilm formation on surfaces. These coatings release controlled doses of antimicrobial agents, inhibiting the growth of biofilms and reducing the risk of infections. They find applications in healthcare, food processing, and the construction industry. Early detection of biofilms is crucial for effective treatment. Advanced detection methods, such as biosensors and imaging techniques, have emerged. These technologies enable real-time monitoring and assessment of biofilm development, allowing for timely intervention. Researchers have developed novel strategies to disrupt biofilms, including using enzymes, bacteriophages, and quorum-sensing inhibitors. These approaches target the biofilm structure and the signalling mechanisms that enable microorganisms to coordinate their activities within the biofilm. Approaches: Biotechnology and genomics have enabled a better understanding of the biology of biofilms. By deciphering the genetic makeup of biofilm-forming microorganisms, researchers can develop targeted therapies and interventions, leading to more effective treatments.

Key Market Players

• Smith+Nephew healthcare private limited
• ConvaTec Group plc
• Zimmer Biomet Holdings, Inc.
• Molnlycke Healthcare AB
• Organogenesis Inc.
• Integra LifeSciences Holdings Corp
• B. Braun Melsungen AG
• PAUL HARTMANN AG
• Medline Industries Inc.
• Welcare Industries S.p.A.

Report Scope:

In this report, the Global Biofilms Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biofilms Treatment Market, By Product:

• Debridement Equipment
• Gauzes & Dressings
• Gels
• Ointments & Sprays Grafts & Matrices
• Wipes
• Pads & Lavage Solutions

Biofilms Treatment Market, By Wound Type:

• Burns & Open Wounds
• Diabetic Foot Ulcers
• Pressure Ulcers
• Traumatic & Surgical Wounds
• Venous Leg Ulcers

Biofilms Treatment Market, By End user:

• Home Care Settings
• Hospitals
• ASCs & Wound Care Centres

Biofilms Treatment Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Biofilms Treatment Market.

Available Customizations:

Global Biofilms Treatment market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biofilms Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Debridement Equipment, Gauzes & Dressings, Gels, Ointments & Sprays Grafts & Matrices, Wipes, Pads & Lavage Solutions)
  • 5.2.2. By Wound Type (Burns & Open Wounds, Diabetic Foot Ulcers, Pressure Ulcers, Traumatic & Surgical Wounds, Venous Leg Ulcers)
  • 5.2.3. By End user (Home Care Settings, Hospitals, ASCs & Wound Care Centres)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Biofilms Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Wound Type
  • 6.2.3. By End user
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Biofilms Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Wound Type
      • 6.3.1.2.3. By End user
  • 6.3.2. Canada Biofilms Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Wound Type
      • 6.3.2.2.3. By End user
  • 6.3.3. Mexico Biofilms Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Wound Type
      • 6.3.3.2.3. By End user

7. Europe Biofilms Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Wound Type
  • 7.2.3. By End user
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Biofilms Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Wound Type
      • 7.3.1.2.3. By End user
  • 7.3.2. United Kingdom Biofilms Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Wound Type
      • 7.3.2.2.3. By End user
  • 7.3.3. Italy Biofilms Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Wound Type
      • 7.3.3.2.3. By End user
  • 7.3.4. France Biofilms Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Wound Type
      • 7.3.4.2.3. By End user
  • 7.3.5. Spain Biofilms Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Wound Type
      • 7.3.5.2.3. By End user

8. Asia-Pacific Biofilms Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Wound Type
  • 8.2.3. By End user
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Biofilms Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Wound Type
      • 8.3.1.2.3. By End user
  • 8.3.2. India Biofilms Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Wound Type
      • 8.3.2.2.3. By End user
  • 8.3.3. Japan Biofilms Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Wound Type
      • 8.3.3.2.3. By End user
  • 8.3.4. South Korea Biofilms Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Wound Type
      • 8.3.4.2.3. By End user
  • 8.3.5. Australia Biofilms Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Wound Type
      • 8.3.5.2.3. By End user

9. South America Biofilms Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Wound Type
  • 9.2.3. By End user
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Biofilms Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Wound Type
      • 9.3.1.2.3. By End user
  • 9.3.2. Argentina Biofilms Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Wound Type
      • 9.3.2.2.3. By End user
  • 9.3.3. Colombia Biofilms Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Wound Type
      • 9.3.3.2.3. By End user

10. Middle East and Africa Biofilms Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Wound Type
  • 10.2.3. By End user
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Biofilms Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Wound Type
      • 10.3.1.2.3. By End user
  • 10.3.2. Saudi Arabia Biofilms Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Wound Type
      • 10.3.2.2.3. By End user
  • 10.3.3. UAE Biofilms Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Wound Type
      • 10.3.3.2.3. By End user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Smith+Nephew healthcare private Limited.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. ConvaTec Group plc
• 14.3. Zimmer Biomet Holdings, Inc.
• 14.4. Molnlycke Healthcare AB
• 14.5. Organogenesis Inc.
• 14.6. Integra LifeSciences Holdings Corp
• 14.7. B. Braun Melsungen AG
• 14.8. PAUL HARTMANN AG
• 14.9. Medline Industries Inc.
• 14.10. Welcare Industries S.p.A

15. Strategic Recommendations

16. About Us & Disclaimer